Aphria Germany (Tilray Germany)
About Aphria Germany (Tilray Germany)
Tilray Germany, formerly Aphria Germany, operates one of the most advanced medical cannabis production facilities in Europe, located in Neumünster, Schleswig-Holstein. The facility holds one of three BfArM domestic cultivation licenses and grows cannabis under EU-GMP conditions. As part of Tilray Brands, the operation serves as a key hub for European medical cannabis supply.
Key Facts
- 1Operates a purpose-built facility in Neumünster with BfArM cultivation license
- 2One of three domestic cannabis producers licensed in Germany
- 3Merged with Tilray in 2021 as part of the Aphria-Tilray merger
- 4Facility includes cultivation, processing, and packaging under one roof
Latest News
Tilray's Multi-Sector Bet Tests Cannabis Investor Patience
TLRY's expansion beyond cannabis into alcohol and wellness creates revenue diversification but raises questions about capital allocation efficiency and core competency focus.
Tilray's Beverage Expansion Tests Cannabis Diversification Playbook
TLRY's alcohol portfolio now generates more revenue than cannabis operations, marking a strategic pivot that challenges traditional sector valuations.
Frequently Asked Questions
What happened to Aphria Germany?
Aphria Germany became part of Tilray Brands following the merger of Aphria Inc. and Tilray Inc. in 2021. The Neumünster production facility continues to operate under the Tilray banner.
Does Tilray Germany export cannabis?
Yes, the Neumünster facility serves as a European hub for Tilray, producing and distributing medical cannabis to pharmacies in Germany and exporting to other European markets where Tilray operates.
Cannabis Laws
Products
- Domestically cultivated medical cannabis
- EU-GMP cannabis flowers
- Medical cannabis extracts
Specialties
Company Details
- Location
- Neumünster, Germany
- Founded
- 2018
- Publicly Traded
- Yes
- Ticker
- NASDAQ:TLRY